Patents by Inventor Torayuki OKUYAMA

Torayuki OKUYAMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11052135
    Abstract: The present invention provides, among other things, compositions and methods for CNS delivery of Idursulfase-beta, a human recombinant iduronate-2-sulfatase protein, for effective treatment of Hunter Syndrome. The compositions and methods provided by the present invention effectively reduce symptoms not only in brain and spinal cord but also in peripheral tissues including heart, liver, spleen, lung, and kidney.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: July 6, 2021
    Assignees: GREEN CROSS CORPORATION, MEDIGENEBIO CORPORATION
    Inventors: Torayuki Okuyama, Thong-Gyu Jin, Han-Yeul Byun, Jin-Wook Seo, Byoung-Ju Lee, Yong-Chul Kim, In-Young Jang, Kyuhyun Lee
  • Publication number: 20200268857
    Abstract: The present invention provides, among other things, compositions and methods for CNS delivery of Idursulfase-beta, a human recombinant iduronate-2-sulfatase protein, for effective treatment of Hunter Syndrome. The compositions and methods provided by the present invention effectively reduce symptoms not only in brain and spinal cord but also in peripheral tissues including heart, liver, spleen, lung, and kidney.
    Type: Application
    Filed: December 21, 2016
    Publication date: August 27, 2020
    Applicants: GREEN CROSS CORPORATION, MediGeneBio Corporation
    Inventors: Torayuki OKUYAMA, Thong-Gyu JIN, Han-Yeul BYUN, Jin-Wook SEO, Byoung-Ju LEE, Yong-Chul KIM, In-Young JANG, Kyuhyun LEE